Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This indicates a small platform update rather than changes to the study details or the information shown on the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a small backend/content update to the page template.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This appears to be a minor version update that does not alter the study content or user-facing features.SummaryDifference0.0%

- Check55 days agoChange DetectedSteatotic Liver Disease was added to the page's disease terms and Fatty Liver Disease was removed. This update updates the page’s terminology to reflect current naming conventions for liver disease and may affect how readers locate information related to these conditions.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page's revision identifier was updated from v3.6.0 to v3.6.3, indicating an internal update to the site interface; no study-specific content changes are reflected in this revision.SummaryDifference0.0%

- Check84 days agoChange DetectedNew sections for How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading have been added. The page now indicates recruitment is closed (no longer looking for participants) and includes a revision note for version 3.6.0.SummaryDifference0.4%

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.